Sleep Apnea Increases Risk for Cardiovascular Risk Factors and Events
By Lori Solomon HealthDay Reporter
FRIDAY, July 19, 2024 -- Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the Journal of the American Heart Association.
Chance Strenth, Ph.D., from University of Texas Southwestern Medical Center Dallas, and colleagues assessed the prevalence of probable OSA and its relationship with cardiovascular risks and diseases. The analysis included data from 9,887 community-dwelling adults participating in the National Health and Nutrition Examination Survey (2013 to 2018).
The researchers found individuals with probable OSA had a significantly higher prevalence of health conditions, including hypertension (adjusted prevalence ratio [aPR], 1.19), diabetes (aPR, 1.17), metabolic syndrome (aPR, 1.14), heart attack (aPR, 1.63), stroke (aPR, 1.41), and any CVD event (aPR, 1.36) when adjusting for relevant factors. Young adults (ages 20 to 40 years) with probable OSA had higher prevalence rates of any CVD events (aPR, 3.44), hypertension (aPR, 1.45), metabolic syndrome (aPR, 1.25), and angina (aPR, 10.39).
"While cross-sectional, [the study] emphasizes that health care providers should recognize OSA as significantly associated with CVDs and its precursor risks in young adults, stressing proactive care and screening to reduce CVD risk in this population," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Hypertensive Disorders of Pregnancy Adversely Affect Preemie Neurodevelopment
THURSDAY, May 1, 2025 -- Maternal hypertensive disorders of pregnancy (HDP) are associated with adverse cognitive and language development in preterm infants at 2 years' corrected...
Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension
WEDNESDAY, April 30, 2025 -- For patients with uncontrolled and treatment-resistant hypertension, lorundrostat is associated with greater reductions in blood pressure than...
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.